Skip to main content

AdvanSix Inc.

corporate_fare Company Profile

AdvanSix Inc.

ASIX·NYSE·Industrial Applications And Services·CIK 0001673985

AdvanSix Inc. is an integrated chemistry company that produces essential materials for diverse end markets. The company’s five U.S.-based manufacturing facilities play a critical role in global supply chains, delivering products for customers in building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics, among other end markets. AdvanSix operates in the industries of nylon solutions, plant nutrients, and chemical intermediates. Its key product lines include Nylon Solutions, which encompasses Nylon and Caprolactam. AdvanSix sells its Nylon 6 resin globally, primarily under the Aegis® brand name. Nylon 6 is a polymer resin used by customers to produce fibers, filaments, engineered plastics, and films for end-products such as carpets, automotive and electric components, sports apparel, and food packaging. Caprolactam is the key monomer for Nylon 6 resin production. AdvanSix internally polymerizes caprolactam into Aegis® Nylon 6 Resin and also sells unconsumed caprolactam to customers who use it to manufacture polymer resins for fibers, compounds, and other nylon products. AdvanSix was separated from Honeywell International Inc. on October 1, 2016, through a distribution of its common stock to Honeywell shareholders.

AdvanSix Inc. (NYSE:ASIX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for ASIX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-17, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for ASIX spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • AdvanSix Refinances Debt with $425M Credit Facilities, Extending Maturity to 2031
  • AdvanSix Q2 Earnings Plunge 90% as Margins Crumble; New CFO Takes Helm
  • AdvanSix Q2 Misses Across the Board, Guides Q3 Pricing Lower
  • AdvanSix Reports Significant Q1 Loss, Sharp Decline in Profitability Amid Operational Challenges
  • AdvanSix Reports Q1 2026 Net Loss and Significant Profit Decline; Pursues Strategic DEF Expansion

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.52B
Net Income
$49.29M
Diluted EPS
$1.80
Op. Cash Flow
$122.86M
Free Cash Flow
$6.42M
Gross Profit
$164.94M
Cash & Equivalents
$19.77M
Debt / Equity
0.00×
Net Margin
3.2%
Shares Outstanding
26.86M sh
Source: 10-K · filed 2026-02-20 · accession 0001673985-26-000008

Short Interest & Short Volume

2.02 days to cover

FINRA reported short interest of 513,398 shares in ASIX as of the September 15, 2026 settlement, a 15.5% decrease from the prior period — about 2.0 days to cover at its recent average daily volume. On October 2, 2026, 49.1% of ASIX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)513,398 shares as of September 15, 2026
Change vs prior period▼ 15.5%
Days to cover2.02 at avg daily volume of 254,731
Daily short volume (FINRA facilities)49.1% of 79,238 shares on October 2, 2026
5-day average short volume47.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$16.22
52-week range · as of 2026-08-17 $14.1 – $26.73
Market cap
$437.96M
Volume
239.9K (0.9× avg)
3-mo avg 269.2K
Live data · 2026-10-03 13:20 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ASIX - Latest Insights

ASIX
Aug 17, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.49
Real-time Price: $16.22 info
Change: -$0.270 (-2%) info
Market Cap: $437.959M info
ASIX
Aug 07, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $16.48
Real-time Price: $16.22 info
Change: -$0.260 (-2%) info
Market Cap: $437.959M info
ASIX
Aug 07, 2026, 6:40 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $18.00
Real-time Price: $16.22 info
Change: -$1.78 (-10%) info
Market Cap: $437.959M info
ASIX
May 08, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $20.34
Real-time Price: $16.22 info
Change: -$4.12 (-20%) info
Market Cap: $437.959M info
ASIX
May 08, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.30
Real-time Price: $16.22 info
Change: -$8.08 (-33%) info
Market Cap: $437.959M info
ASIX
May 07, 2026, 1:54 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $24.99
Real-time Price: $16.22 info
Change: -$8.77 (-35%) info
Market Cap: $437.959M info
ASIX
Apr 13, 2026, 6:49 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $23.30
Real-time Price: $16.22 info
Change: -$7.08 (-30%) info
Market Cap: $437.959M info
ASIX
Feb 20, 2026, 4:17 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $18.79
Real-time Price: $16.22 info
Change: -$2.57 (-14%) info
Market Cap: $437.959M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets